Health care stocks were mixed premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.4%.
Nano-X Imaging (NNOX) shares were up past 15% after the company said it received 510(k) clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.
Patterson Companies (PDCO) stock was over 7% higher after the company posted an increase in its fiscal Q2 net sales.
Mesoblast (MESO) shares were down more than 4% even after the company said the US Food and Drug Administration granted the company's second-generation cell therapy, Revascor, a regenerative medicine advanced therapy designation.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。